- Cambridge, Massachusetts, United States
- Hybrid
- Full-time · Manager
- $209K–$254K per year
- 5+ years
Lead the development and implementation of the Model-Informed Drug Development strategy for drugs and other therapeutic agents in clinical development, partnering with Clinical Pharmacology and other quantitative functions.
Compensation
Cambridge Crossing: $209,250 - $253,565
Responsibilities
- Partner with the Clinical Pharmacology lead to develop the MIDD strategy and define the PMx plan for assigned assets.
- Lead integration across quantitative disciplines to develop and execute a coherent modeling and data strategy.
- Lead the planning, execution, interpretation, and reporting of formal PMx analyses supporting clinical study reports, health authority submissions, and responses to regulatory questions.
- Translate complex modeling results into clear, actionable recommendations that inform asset strategy, development plans, and governance decisions.
- Serve as the MIDD subject matter expert, partnering with Clinical Pharmacology and other quantitative functions to influence development decisions for therapeutic agents.
Requirements
- Advanced degree in a relevant scientific or quantitative field, such as an MS, PhD, or PharmD
- Nice to have: Quantitative Systems Pharmacology
- Nice to have: Physiologically Based Pharmacokinetic modeling
